[Restriction of the lesion focus in myocardial infarct].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents; D006821:Hyaluronoglucosaminidase
Ob ogranichenii ochaga porazheniia pri infarkte miokarda.